These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

567 related items for PubMed ID: 15869543

  • 1. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
    Baumann L, Slezinger A, Halem M, Vujevich J, Martin LK, Black L, Bryde J.
    Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
    [Abstract] [Full Text] [Related]

  • 2. Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for the treatment of palmar hyperhidrosis.
    Baumann L, Slezinger A, Halem M, Vujevich J, Mallin K, Charles C, Martin LK, Black L, Bryde J.
    Dermatol Surg; 2005 Mar; 31(3):263-70. PubMed ID: 15841624
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
    Lowe NJ, Glaser DA, Eadie N, Daggett S, Kowalski JW, Lai PY, North American Botox in Primary Axillary Hyperhidrosis Clinical Study Group.
    J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
    [Abstract] [Full Text] [Related]

  • 5. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J, Simonart T.
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [Abstract] [Full Text] [Related]

  • 6. Botulinum toxin-B and the management of hyperhidrosis.
    Baumann LS, Halem ML.
    Clin Dermatol; 2004 May; 22(1):60-5. PubMed ID: 15158547
    [Abstract] [Full Text] [Related]

  • 7. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
    Güleç AT.
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
    [Abstract] [Full Text] [Related]

  • 8. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study.
    Heckmann M, Plewig G, Hyperhidrosis Study Group.
    Arch Dermatol; 2005 Oct; 141(10):1255-9. PubMed ID: 16230563
    [Abstract] [Full Text] [Related]

  • 9. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
    Heckmann M, Ceballos-Baumann AO, Plewig G, Hyperhidrosis Study Group.
    N Engl J Med; 2001 Feb 15; 344(7):488-93. PubMed ID: 11172190
    [Abstract] [Full Text] [Related]

  • 10. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis.
    Talarico-Filho S, Mendonça DO Nascimento M, Sperandeo DE Macedo F, DE Sanctis Pecora C.
    Dermatol Surg; 2007 Jan 15; 33(1 Spec No.):S44-50. PubMed ID: 17241414
    [Abstract] [Full Text] [Related]

  • 11. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary axillary hyperhidrosis: a study in 83 patients.
    Lecouflet M, Leux C, Fenot M, Célerier P, Maillard H.
    J Am Acad Dermatol; 2013 Dec 15; 69(6):960-4. PubMed ID: 24035554
    [Abstract] [Full Text] [Related]

  • 12. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ.
    J Drugs Dermatol; 2011 Sep 15; 10(9):1013-5. PubMed ID: 22052270
    [Abstract] [Full Text] [Related]

  • 13. Botulinum toxin type B: a new therapy for axillary hyperhidrosis.
    Nelson L, Bachoo P, Holmes J.
    Br J Plast Surg; 2005 Mar 15; 58(2):228-32. PubMed ID: 15710119
    [Abstract] [Full Text] [Related]

  • 14. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.
    Naumann M, Lowe NJ.
    BMJ; 2001 Sep 15; 323(7313):596-9. PubMed ID: 11557704
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Botulinum toxin type B for treatment of axillar hyperhidrosis.
    Dressler D, Adib Saberi F, Benecke R.
    J Neurol; 2002 Dec 15; 249(12):1729-32. PubMed ID: 12529798
    [Abstract] [Full Text] [Related]

  • 17. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary palmar hyperhidrosis: a study of 28 patients.
    Lecouflet M, Leux C, Fenot M, Célerier P, Maillard H.
    J Am Acad Dermatol; 2014 Jun 15; 70(6):1083-7. PubMed ID: 24630001
    [Abstract] [Full Text] [Related]

  • 18. Successful treatment of axillary hyperhidrosis with very low doses of botulinum toxin B: a pilot study.
    Hecht MJ, Birklein F, Winterholler M.
    Arch Dermatol Res; 2004 Feb 15; 295(8-9):318-9. PubMed ID: 14648075
    [No Abstract] [Full Text] [Related]

  • 19. Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study.
    Glogau RG.
    Dermatol Surg; 2007 Jan 15; 33(1 Spec No.):S76-80. PubMed ID: 17241418
    [Abstract] [Full Text] [Related]

  • 20. A double-blinded, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B)-purified neurotoxin complex for the treatment of crow's feet: a double-blinded, placebo-controlled trial.
    Baumann L, Slezinger A, Vujevich J, Halem M, Bryde J, Black L, Duncan R.
    Dermatol Surg; 2003 May 15; 29(5):508-15. PubMed ID: 12752519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.